Could a psychedelic compound help heal PTSD? new trial aims to find out.
NCT ID NCT07570654
First seen May 16, 2026 · Last updated May 16, 2026
Summary
This study tests whether a lab-made psilocybin drug called COMP360 can reduce symptoms of post-traumatic stress disorder (PTSD). About 300 adults with PTSD will receive either a high or low dose of COMP360 along with support from a trained team. The main goal is to see if symptoms improve after 8 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.